CRDL:CA Cardiol Therapeutics Heal the heart with innovative science.pharmaceutical investingbiotech stockstsx:crdl
CDX:AU Cardiex Limited Biomarker technologies and digital solutions to address the world’s largest health disorders.asx:cdxmedical device investingasx stocksmedical device stocks
Nextech3D.ai Reports Strong 20% Q2 Sequential Revenue Growth With Gross Margins of 88% For the Three Months Ended September 30, 2025 ("Q2 2026")
Appoints global biopharma leader Paul Carter as Non-Executive Director to support next phase of strategic growth